Provider Comparisons8 min read

SkinnyRx vs EnhanceMD: Cheapest GLP-1 Access vs Flat-Rate Lab-Monitored Care in 2026

SkinnyRx is the lower-friction pick if you want cheap medication-first GLP-1 access with month-to-month flexibility. EnhanceMD is the better fit if you want flat-rate dosing, included metabolic labs, and more clinical monitoring around the same compounded GLP-1 category.

Short Answer: SkinnyRx vs EnhanceMD

Choose SkinnyRx if you want the cheaper, no-frills medication access route. The local SkinnyRx review rates it 4.3/5 and lists compounded injectable semaglutide from $149.25/month, compounded semaglutide tablets at $249/month, compounded tirzepatide at $299/month, free shipping, an included consultation, injection supplies, basic messaging support, provider access for dose adjustments, and month-to-month cancellation.

Choose EnhanceMD if you want flatter pricing and more monitoring around the same compounded GLP-1 category. The local EnhanceMD review also rates it 4.3/5 and lists GLP-1 Core semaglutide at $49 first month then $212/month, GLP-1 Advanced tirzepatide at $99 first month then $280/month, GLP-1 Elite semaglutide plus tirzepatide combo at $189 first month then $322/month, tirzepatide microdosing at $169/month, NAD+ injections at $169/month, metabolic lab testing every 6 months, and the same price at every dose.

So this is not a pure quality split. It is a fit split. SkinnyRx is better for lowest simple access. EnhanceMD is better for flat-rate dosing, lab monitoring, and a more clinical follow-up model.

Price-sensitive buyers should start with SkinnyRx, SkinnyRx semaglutide, or SkinnyRx tirzepatide. Buyers who value labs and predictable dosing should compare EnhanceMD, EnhanceMD semaglutide, or EnhanceMD tirzepatide.

Quick Comparison

Best fit: SkinnyRx is best for shoppers who already know they want semaglutide or tirzepatide and want straightforward telehealth access. EnhanceMD is best for shoppers who want dose-adjustment support, metabolic labs, and pricing that does not rise with higher doses.

Rating: SkinnyRx is 4.3/5. EnhanceMD is 4.3/5.

Semaglutide price: SkinnyRx lists compounded injectable semaglutide from $149.25/month and compounded semaglutide tablets at $249/month. EnhanceMD lists semaglutide at $49 first month, then $212/month in the local review. Its Trustpilot profile shows a newer promo saying start semaglutide for $249 all included, with WELCOME10 for $10 off the first month. Treat that as a live-price discrepancy and verify checkout.

Tirzepatide price: SkinnyRx lists compounded tirzepatide at $299/month. EnhanceMD lists tirzepatide at $99 first month, then $280/month.

Formats: SkinnyRx offers injectable semaglutide, semaglutide tablets, and tirzepatide. EnhanceMD offers compounded semaglutide, compounded tirzepatide, a semaglutide plus tirzepatide combo plan, tirzepatide microdosing, and NAD+ injections, but the local review says injections only for GLP-1 care.

Labs and coaching: EnhanceMD includes metabolic lab testing every 6 months and ongoing provider support. SkinnyRx is more medication-first, with messaging support and dose adjustments, but no standard coaching or routine lab monitoring listed.

Cancellation and refund terms: SkinnyRx is month-to-month in the local review, but official pages say full refund only before licensed provider prescription review is complete. EnhanceMD offers a money-back guarantee if found medically ineligible.

Pricing and True Monthly Cost

SkinnyRx has the lowest advertised semaglutide injection price in the local review. At $149.25/month, injectable semaglutide is about $1,791/year. Semaglutide tablets at $249/month are about $2,988/year. Tirzepatide at $299/month is about $3,588/year.

EnhanceMD costs more for semaglutide after month one, but the year-one math is still competitive if the local review pricing is current. Semaglutide is $49 for month one plus 11 months at $212, or about $2,381 for year one. Tirzepatide is $99 for month one plus 11 months at $280, or about $3,179 for year one. GLP-1 Elite is $189 for month one plus 11 months at $322, or about $3,731 for year one. Tirzepatide microdosing at $169/month is about $2,028/year.

The practical takeaway: SkinnyRx wins on simple advertised semaglutide injection pricing. EnhanceMD can beat SkinnyRx on tirzepatide if the $99 first month and $280/month ongoing price still appears at checkout.

EnhanceMD also has a value argument that is not just price. The local review says its $212/month semaglutide price stays the same at every dose, with metabolic labs every 6 months. That matters if a buyer wants monitoring and does not want dose-escalation price surprises.

Do not treat any number here as guaranteed until checkout. EnhanceMD has page-to-page price variation, including the Trustpilot profile promo that says semaglutide starts at $249 all included. SkinnyRx also notes that website pricing may not always be clear until the intake process starts.

Medication Options and Clinical Model

SkinnyRx is medication-first. The local review lists compounded injectable semaglutide, compounded semaglutide tablets, and compounded tirzepatide. The program includes a medical evaluation by a licensed provider, a prescription if appropriate, monthly medication delivery, provider access for dose adjustments, basic messaging support, and injection supplies.

That simplicity is the appeal. SkinnyRx is strongest for people who already know they want semaglutide or tirzepatide and want straightforward delivery without a broader wellness program. The tradeoff is clear: no coaching or lifestyle support, limited provider interaction, messaging-based care, no standard video appointments, compounded only, no brand-name option, and pricing that may not be fully clear until intake.

EnhanceMD is more monitoring-oriented. The local review lists compounded semaglutide, compounded tirzepatide, GLP-1 Elite semaglutide plus tirzepatide combo, tirzepatide microdosing, and NAD+ injections. It includes a medical consultation with a licensed provider, a compounded prescription if appropriate, dose adjustments as needed, ongoing provider support, same-price dosing, and metabolic lab testing every 6 months.

Be careful with the GLP-1 Elite combo plan. It is a listed EnhanceMD plan, not proof that combining semaglutide and tirzepatide is automatically better. That decision belongs with the clinician reviewing the patient, medical history, side effects, and goals.

Neither local review frames these as brand-name Wegovy, Ozempic, Zepbound, or Mounjaro programs. For molecule background, compare semaglutide, tirzepatide, and compounded vs brand GLP-1.

Refunds, Cancellation, and Buyer Risk

SkinnyRx is easier to understand before prescribing than after prescribing. The local review says month-to-month and cancel anytime. Official SkinnyRx pages fetched on June 23, 2026 say a buyer may cancel and receive a full refund any time before a licensed provider completes prescription review. Once the prescription has been completed and fulfillment begins, the order becomes non-refundable. Its terms also say membership cancellation applies prospectively beginning with the next billing period.

That means the safest cancellation window is early. If you do not want another month, cancel before the next billing cycle and before the next shipment is prepared. If you are still in provider review, the refund position is cleaner than it is after prescription completion and fulfillment.

EnhanceMD has a different risk profile. The local review says it offers a money-back guarantee if the user is found medically ineligible. That is useful, but it should not be read as a broad satisfaction guarantee.

For reputation context, EnhanceMD has a claimed Trustpilot profile since January 2024, a paid Trustpilot subscription, a 4.1 TrustScore from 158 reviews, 67 reviews in the last 12 months, 68% 5-star reviews, 10% 4-star, 5% 3-star, 4% 2-star, and 13% 1-star. Trustpilot says reviews are customer opinions and are not fact-checked.

The review pattern is mixed but useful. Many customers praise helpful staff, professionalism, onboarding, customer service, and a personalized approach. Some complaints mention product use or storage, effectiveness, initial interactions, lab communication, and delays.

Safety and Evidence Context

Clinical trial data supports semaglutide and tirzepatide as molecules. It does not prove that SkinnyRx, EnhanceMD, any compounded product, any pharmacy, or any individual patient will match trial outcomes.

For semaglutide, STEP 1 enrolled 1,961 adults with overweight or obesity without diabetes. Once-weekly semaglutide 2.4 mg plus lifestyle intervention produced 14.9% mean body-weight loss at 68 weeks, compared with 2.4% with placebo. At least 5% weight loss occurred in 86.4% vs 31.5%, at least 10% in 69.1% vs 12.0%, and at least 15% in 50.5% vs 4.9%. Mean body-weight change was -15.3 kg vs -2.6 kg.

For tirzepatide, SURMOUNT-1 enrolled 2,539 adults with obesity or overweight and at least one weight-related complication, excluding diabetes. Prior PeptidePub drafts use efficacy-estimand mean weight loss of 16.0%, 21.4%, and 22.5% for 5 mg, 10 mg, and 15 mg tirzepatide vs 2.4% placebo at 72 weeks. At least 5% weight loss occurred in 89%, 96%, and 96% vs 28% with placebo. At least 20% loss occurred in 55% at 10 mg and 63% at 15 mg vs 1.3% with placebo.

FDA context matters more with compounded routes. FDA says compounded drugs are not FDA-approved finished products. FDA has warned about fraudulent compounded GLP-1 labels, non-existent or misidentified compounding pharmacies, dosing errors, doses beyond approved labels, adverse events, and semaglutide salt forms.

Before paying, confirm licensed provider review, pharmacy identity, exact medication form, concentration, instructions, refill timing, side-effect support, refund cutoff, and whether the product is compounded or brand-name.

Who Should Choose SkinnyRx

Choose SkinnyRx if your priority is simple GLP-1 access at the lowest advertised semaglutide injection price in this comparison. The strongest use case is a buyer who already understands semaglutide or tirzepatide, does not want a coaching-heavy program, and wants medication delivery with provider messaging and dose adjustments if prescribed.

SkinnyRx is especially compelling for semaglutide price shoppers. The local review lists compounded injectable semaglutide from $149.25/month, with no separate membership fee called out. It also lists compounded semaglutide tablets at $249/month and compounded tirzepatide at $299/month.

The drawbacks are part of the bargain. SkinnyRx is no-frills. The local review says no coaching or lifestyle support, limited provider interaction, messaging-based care, no standard video appointments, compounded only, no brand-name pathway, and pricing that may not always be clear until the process starts.

Use SkinnyRx for general access, SkinnyRx semaglutide for semaglutide shoppers, and SkinnyRx tirzepatide for tirzepatide shoppers. For broader comparison shopping, read the SkinnyRx review, SkinnyRx vs MEDVi, SkinnyRx vs Breeze Meds, Novi vs SkinnyRx, and Direct Meds vs SkinnyRx.

Who Should Choose EnhanceMD

Choose EnhanceMD if you want the same price at every dose, metabolic lab testing every 6 months, and more ongoing provider support. It is the better fit for buyers who value monitoring more than the absolute lowest semaglutide price.

FAQ

Cheaper? SkinnyRx for semaglutide: $149.25/month vs EnhanceMD $49 first month then $212/month. EnhanceMD may win tirzepatide after month one: $280/month vs $299/month.

Labs? EnhanceMD includes metabolic labs every 6 months. SkinnyRx does not list routine labs.

Brand-name drugs? No in the local reviews. Both are compounded-only.

Bottom Line

SkinnyRx wins for cheapest simple semaglutide access. EnhanceMD wins for flat-rate dosing, labs, and lower listed tirzepatide ongoing cost.

We negotiate GLP-1 discounts you won't find on provider sites

Price drops happen weekly. Get notified before they expire, plus exclusive deals and new program launches. No spam, unsubscribe anytime.